Screener
Inspire Medical Systems INSP Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Inspire Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001609550-26-000023
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from the exercise of stock options | 109 | 6,441 |
| Share repurchase of common stock | — | (75,009) |
| Payment of taxes on net share settlement of equity awards | (7,591) | (19,192) |
| Net cash (used in) financing activities | (7,482) | (87,760) |
| Effect of exchange rate on cash | 1 | (252) |
| (Decrease) in cash and cash equivalents | (5,881) | (96,268) |
| Cash and cash equivalents at beginning of period | 104,813 | 150,150 |
| Cash and cash equivalents at end of period | $98,932 | $53,882 |
Item 1. Financial Statements.
FAQ
- What is Inspire Medical Systems's financing cash flow?
- Inspire Medical Systems (INSP) reported financing cash flow of -$7.48M in Q1 2026.
- How has Inspire Medical Systems's financing cash flow changed year-over-year?
- Inspire Medical Systems's financing cash flow increased by 91.5% year-over-year, from -$87.76M to -$7.48M.
- What is the long-term trend for Inspire Medical Systems's financing cash flow?
- Over 3 years (2021 to 2025), Inspire Medical Systems's financing cash flow has grown at a 132.2% compound annual growth rate (CAGR), from $14.95M to -$187.15M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Inspire Medical Systems's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude